Industries · Biotech & Life Sciences

AI that survives contact with the lab and the IRB.

For founder-scientists, R&D leads, and CSOs at biotech and life-sciences organizations. Built by people who've sat in the rooms where scientific credibility is on the line.

Why we're different here

A biophysicist and a pharma scientist on the founding team.

Generic AI consultants don't understand your constraints. Most have never worked inside a lab, navigated IRB review, or answered to an FDA auditor. Our founding team has done all three.

That insider fluency means we ask the right questions early — about data provenance, validation, reproducibility, and what scientific rigor actually costs to maintain — instead of producing a deliverable that gets rejected the moment it meets your QA team.

Domains
Biotech, pharma, diagnostics, devices
Compliance
HIPAA · 21 CFR Part 11 · GxP-aware
Stages
Pre-seed through commercial
Format
Remote + on-site for security work
Where AI fits in research orgs

Six places we typically build.

01

Literature & competitive intel

Curated, citation-grounded synthesis across PubMed, patents, and conference abstracts — with provenance.

02

Lab notebook augmentation

Structured capture, retrieval, and summarization across electronic lab notebooks — rigor preserved.

03

Regulatory documentation

Drafts of protocols, INDs, and study reports with Human-in-the-Loop review baked in.

04

Grant & manuscript support

Editorial systems that hold up to peer review. Speed without the slop.

05

Investor & board narratives

Translating science into the story your board, your CDA partners, and your buyers need to hear.

06

Internal scientific Q&A

A grounded internal assistant for your own SOPs, protocols, and institutional knowledge.

Engagement formats

Built around scientific work, not enterprise IT.

Bring a use case. We'll bring the rigor.

A 30-minute discovery call is the fastest way to find out whether AIXUS is the right fit for your science.

Book a discovery call